Clarity Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,455
Closed -$303K 149
2024
Q3
$303K Buy
+10,455
New +$305K 0.04% 120
2023
Q4
Sell
-9,108
Closed -$302K 121
2023
Q3
$302K Buy
9,108
+417
+5% +$14.7K 0.05% 91
2023
Q2
$319K Buy
+8,691
New +$338K 0.05% 82
2023
Q1
Sell
-4,173
Closed -$214K 75
2022
Q4
$214K Buy
+4,173
New +$200K 0.04% 97
2021
Q2
Sell
-25,405
Closed -$920K 137
2021
Q1
$920K Buy
25,405
+8,397
+49% +$298K 0.19% 66
2020
Q4
$626K Buy
+17,008
New +$624K 0.15% 60

Other funds holding PFE

Clarity Financial's PFE Position: Q4 2024 in Review

Clarity Financial sold out of Pfizer (PFE) in Q4 2024, closing a stake of 10,455 shares — an estimated $303K sold.

Clarity Financial first reported a position in PFE in Q4 2020 and held it in 6 quarters. The position peaked at $920K in Q1 2021. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Clarity Financial reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Clarity Financial sold 10,455 Pfizer shares in Q4 2024, an estimated $303K.
  • Clarity Financial first reported a position in Pfizer in Q4 2020 and held it in 6 quarters.
  • Clarity Financial's Pfizer position peaked at $920K in Q1 2021.
  • 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Clarity Financial's 13F filing for Q4 2024, filed 23 Jan 2025.